Sharon Hesterlee's Blog – April 2014 Archive (1)
New Duchenne Therapies in Development
As we finalize the agenda for this year’s Connect Conference, I am once again amazed at how much of a challenge it is to squeeze in all of the talks on different therapeutic approaches to treating Duchenne—in fact, there are too many to cover comprehensively this year. Sometimes it’s good to remember that mutation-specific approaches like exon skipping, although promising and…
ContinueAdded by Sharon Hesterlee on April 24, 2014 at 12:30pm — 3 Comments
Latest Blog Posts
Most Popular Blog Posts
- GSK and Prosensa announce primary endpoint not met in Phase III study of drisapersen
- Positive Phase 1 trial results for SMT C1100 in Duchenne (Summit PLC)
- Now is the time for strength.
- Without Endings There Are No Beginnings…
- Parent Project Muscular Dystrophy awards $50,000 to Dr. Toshifumi Yokota for multi-exon skipping project
- Drug Development Prospects for Duchenne: The Pipeline is rich and deep, with lots of forward momentum
- World Muscle Society Congress: Next Generation Exon-Skipping & Clinical Trial Updates
© 2021 Created by PPMD.
Powered by
Badges | Report an Issue | Privacy Policy | Terms of Service
